Browsing the "Domain Associates" Tag →

26 2015 June
By FinSMEs
0 Comments

Sebacia Completes $22M Series C Financing

Sebacia, Inc., a Duluth, GA-based company dedicated to delivering dermatology treatments, completed a $22m Series C financing. The financing includes $12m...

Read More →
15 2015 June
By FinSMEs
0 Comments

Milestone Pharmaceuticals Closes US$17M Series B Financing

Milestone Pharmaceuticals Inc., a Saint-Laurent, Canada-based clinical stage cardiovascular company in Phase 2, closed a US$17m Series B financing. The...

Read More →
15 2015 January
By FinSMEs
0 Comments

Obalon Therapeutics Completes $30M Financing

Obalon Therapeutics, Inc., a San Diego, California-based medical technology company, completed a $30m financing. This included a $20m Series D...

Read More →
13 2015 January
By FinSMEs
0 Comments

CoLucid Pharmaceuticals Raises $37.1M in Series C Funding

CoLucid Pharmaceuticals, a Durham, North Carolina-based developer of oral lasmiditan that treats migraine headaches, raised $37.1m in Series C funding....

Read More →
21 2014 November
By FinSMEs
0 Comments

BioNano Genomics Completes $53M Series C Financing

BioNano Genomics, Inc., a San Diego, CA-based developer of a genome mapping platform, completed a $53m Series C financing. The...

Read More →
22 2014 September
By FinSMEs
0 Comments

Colorescience Completes $15M Series B Financing

Colorescience, a Carlsbad, CA-based premier luxury mineral makeup company, completed a $15m Series B financing. The round was led by Longwood Fund...

Read More →
04 2014 September
By FinSMEs
0 Comments

Fractyl Laboratories Secures $40M in Series C Funding

Fractyl Laboratories, a Waltham, Mass.-based developer of a device-based endoscopic procedure to treat Type 2 diabetes, secured $40m in Series...

Read More →
30 2014 July
By FinSMEs
0 Comments

Epic Sciences Completes $30M Series C Financing

Epic Sciences, Inc., a San Diego, CA-based biotech company that designs and develops novel diagnostics to personalize and advance the...

Read More →
30 2014 April
By FinSMEs
0 Comments

Otonomy Secures $49M in Series D Financing

Otonomy, a San Diego, CA-based biopharmaceutical company developing therapeutics for diseases for the ear, secured $49m in Series D financing....

Read More →
08 2014 April
By FinSMEs
0 Comments

Sequent Medical Closes $20M Series D VC Financing

Sequent Medical, a Aliso Viejo, California-based medical-device company, closed a $20.0m Series D venture capital financing. The round was led...

Read More →
12 2014 February
By FinSMEs
0 Comments

Lithera Raises $8M in Series C Funding

Lithera, a San Diego, Calif.-based a clinical stage pharmaceutical company, raised $8m in the final close of its Series C...

Read More →
12 2014 February
By FinSMEs
0 Comments

Miramar Labs Raises $10M in Series D Funding

Miramar Labs®, Inc., a Sunnyvale, CA-based medical device manufacturer focused on the treatment of excessive underarm sweat, raised $10m in...

Read More →
10 2014 January
By FinSMEs
0 Comments

Atara Biotherapeutics Holds $13.5M Second Close of Series B Financing

Atara Biotherapeutics, Inc., a Thousand Oaks, CA-based drug development company with a focus on innovative therapies for patients with debilitating diseases,...

Read More →
17 2013 December
By FinSMEs
0 Comments

Atara Biotherapeutics Secures $38.5M in Series B Financing

Atara Biotherapeutics, Inc., a Thousand Oaks, CA-based drug development company with a focus on innovative therapies for patients with debilitating...

Read More →